Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.34
(-2.99%)
CNY 11.34
(-2.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.83 Billion CNY | -1.88% |
| 2022 | 1.86 Billion CNY | 2.05% |
| 2021 | 1.82 Billion CNY | -27.15% |
| 2020 | 2.5 Billion CNY | 4.9% |
| 2019 | 2.39 Billion CNY | 17.2% |
| 2018 | 2.04 Billion CNY | -18.43% |
| 2017 | 2.5 Billion CNY | 41.29% |
| 2016 | 1.77 Billion CNY | 80.13% |
| 2015 | 983.5 Million CNY | 46.24% |
| 2014 | 672.53 Million CNY | 242.94% |
| 2013 | 196.11 Million CNY | 33.61% |
| 2012 | 146.78 Million CNY | 34.66% |
| 2011 | 109 Million CNY | 9.77% |
| 2010 | 99.3 Million CNY | -26.76% |
| 2009 | 135.58 Million CNY | -32.84% |
| 2008 | 201.87 Million CNY | -58.74% |
| 2007 | 489.21 Million CNY | 302.81% |
| 2006 | 121.45 Million CNY | 50.7% |
| 2005 | 80.58 Million CNY | -0.31% |
| 2004 | 80.83 Million CNY | 45.34% |
| 2003 | 55.62 Million CNY | 28.65% |
| 2002 | 43.23 Million CNY | 18.4% |
| 2001 | 36.51 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 572.69 Million CNY | -2.11% |
| 2024 Q1 | 618.03 Million CNY | 41.79% |
| 2024 Q2 | 593.57 Million CNY | -3.96% |
| 2023 FY | 1.83 Billion CNY | -1.88% |
| 2023 Q2 | 523.17 Million CNY | 14.28% |
| 2023 Q1 | 457.78 Million CNY | -2.28% |
| 2023 Q3 | 501.73 Million CNY | -4.1% |
| 2023 Q4 | 435.89 Million CNY | -13.12% |
| 2022 Q1 | 478.44 Million CNY | 5.92% |
| 2022 FY | 1.86 Billion CNY | 2.05% |
| 2022 Q2 | 427.34 Million CNY | -10.68% |
| 2022 Q4 | 468.47 Million CNY | -4.72% |
| 2022 Q3 | 491.67 Million CNY | 15.05% |
| 2021 Q4 | 451.7 Million CNY | 6.19% |
| 2021 Q2 | 472.56 Million CNY | -1.29% |
| 2021 Q3 | 425.38 Million CNY | -9.98% |
| 2021 Q1 | 478.72 Million CNY | 2.28% |
| 2021 FY | 1.82 Billion CNY | -27.15% |
| 2020 FY | 2.5 Billion CNY | 4.9% |
| 2020 Q4 | 468.05 Million CNY | -15.41% |
| 2020 Q3 | 553.31 Million CNY | -26.36% |
| 2020 Q2 | 751.35 Million CNY | 1.92% |
| 2020 Q1 | 737.19 Million CNY | 4.23% |
| 2019 Q1 | 477.29 Million CNY | -1.95% |
| 2019 Q2 | 620.27 Million CNY | 29.96% |
| 2019 Q3 | 587.87 Million CNY | -5.22% |
| 2019 Q4 | 707.27 Million CNY | 20.31% |
| 2019 FY | 2.39 Billion CNY | 17.2% |
| 2018 Q4 | 486.77 Million CNY | 14.19% |
| 2018 Q3 | 426.29 Million CNY | 1.43% |
| 2018 FY | 2.04 Billion CNY | -18.43% |
| 2018 Q1 | 708.21 Million CNY | -8.0% |
| 2018 Q2 | 420.29 Million CNY | -40.65% |
| 2017 Q4 | 769.83 Million CNY | 4.31% |
| 2017 Q3 | 738.04 Million CNY | 44.59% |
| 2017 Q2 | 510.42 Million CNY | 5.31% |
| 2017 Q1 | 484.7 Million CNY | 1.13% |
| 2017 FY | 2.5 Billion CNY | 41.29% |
| 2016 Q3 | 457.04 Million CNY | -3.48% |
| 2016 Q2 | 473.53 Million CNY | 30.92% |
| 2016 Q1 | 361.7 Million CNY | 42.67% |
| 2016 Q4 | 479.26 Million CNY | 4.86% |
| 2016 FY | 1.77 Billion CNY | 80.13% |
| 2015 FY | 983.5 Million CNY | 46.24% |
| 2015 Q3 | 246.52 Million CNY | 2.63% |
| 2015 Q4 | 253.52 Million CNY | 2.84% |
| 2015 Q2 | 240.2 Million CNY | -1.25% |
| 2015 Q1 | 243.24 Million CNY | -8.93% |
| 2014 Q1 | 82.92 Million CNY | 34.39% |
| 2014 Q3 | 145.05 Million CNY | 18.25% |
| 2014 Q4 | 267.1 Million CNY | 84.14% |
| 2014 FY | 672.53 Million CNY | 242.94% |
| 2014 Q2 | 122.67 Million CNY | 47.94% |
| 2013 FY | 196.11 Million CNY | 33.61% |
| 2013 Q2 | 46.39 Million CNY | 8.11% |
| 2013 Q3 | 45.09 Million CNY | -2.79% |
| 2013 Q4 | 61.7 Million CNY | 36.82% |
| 2013 Q1 | 42.91 Million CNY | 3.44% |
| 2012 Q2 | 34.57 Million CNY | -3.36% |
| 2012 Q1 | 35.77 Million CNY | 77.0% |
| 2012 Q4 | 41.48 Million CNY | 18.75% |
| 2012 FY | 146.78 Million CNY | 34.66% |
| 2012 Q3 | 34.93 Million CNY | 1.05% |
| 2011 Q4 | 20.21 Million CNY | -43.83% |
| 2011 FY | 109 Million CNY | 9.77% |
| 2011 Q1 | 25.21 Million CNY | 100.71% |
| 2011 Q2 | 27.58 Million CNY | 9.37% |
| 2011 Q3 | 35.98 Million CNY | 30.48% |
| 2010 Q2 | 30.22 Million CNY | -7.18% |
| 2010 Q4 | 12.56 Million CNY | -47.53% |
| 2010 FY | 99.3 Million CNY | -26.76% |
| 2010 Q1 | 32.56 Million CNY | 4.87% |
| 2010 Q3 | 23.94 Million CNY | -20.77% |
| 2009 Q2 | 33.52 Million CNY | 18.28% |
| 2009 Q1 | 28.34 Million CNY | 28.64% |
| 2009 FY | 135.58 Million CNY | -32.84% |
| 2009 Q4 | 31.05 Million CNY | -27.22% |
| 2009 Q3 | 42.66 Million CNY | 27.26% |
| 2008 Q4 | 22.03 Million CNY | -17.26% |
| 2008 Q2 | 59.04 Million CNY | -37.29% |
| 2008 Q3 | 26.62 Million CNY | -54.9% |
| 2008 Q1 | 94.16 Million CNY | -34.53% |
| 2008 FY | 201.87 Million CNY | -58.74% |
| 2007 Q2 | 136.57 Million CNY | 110.59% |
| 2007 FY | 489.21 Million CNY | 302.81% |
| 2007 Q4 | 143.81 Million CNY | -0.1% |
| 2007 Q3 | 143.96 Million CNY | 5.41% |
| 2007 Q1 | 64.85 Million CNY | 73.7% |
| 2006 Q3 | 32.13 Million CNY | 28.01% |
| 2006 Q1 | 26.86 Million CNY | 63.17% |
| 2006 FY | 121.45 Million CNY | 50.7% |
| 2006 Q2 | 25.1 Million CNY | -6.55% |
| 2006 Q4 | 37.33 Million CNY | 16.18% |
| 2005 Q4 | 16.46 Million CNY | -14.88% |
| 2005 FY | 80.58 Million CNY | -0.31% |
| 2005 Q2 | 26.85 Million CNY | 49.76% |
| 2005 Q1 | 17.92 Million CNY | 22.71% |
| 2005 Q3 | 19.34 Million CNY | -27.96% |
| 2004 Q4 | 14.61 Million CNY | -30.51% |
| 2004 FY | 80.83 Million CNY | 45.34% |
| 2004 Q1 | 23.16 Million CNY | 43.39% |
| 2004 Q2 | 22.03 Million CNY | -4.85% |
| 2004 Q3 | 21.02 Million CNY | -4.6% |
| 2003 Q3 | 9.83 Million CNY | 0.0% |
| 2003 Q4 | 16.15 Million CNY | 64.2% |
| 2003 FY | 55.62 Million CNY | 28.65% |
| 2002 FY | 43.23 Million CNY | 18.4% |
| 2001 FY | 36.51 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.18 Billion CNY | 16.396% |
| Zhejiang Zhenyuan Share Co., Ltd. | 762.64 Million CNY | -140.07% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 458.96 Million CNY | -298.913% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 187.93 Million CNY | -874.217% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 347.72 Million CNY | -426.541% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 10.7 Billion CNY | 82.892% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 620.91 Million CNY | -194.87% |
| Boai NKY Medical Holdings Ltd. | 894.38 Million CNY | -104.709% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 808 Million CNY | -126.595% |